HIV-l, the etiologic agent of AIDS, is often complicated with neurologic disorders (1) . HIV-I-associated neurologic disease occurs as the initial presenting clinical manifestation of AIDS in 3-7% of infected patients, but in up to 18% of children (2) . In infants infected with HIV-l, the CNS is involved earlier than in adults, partly related to the fact that the retroviral infection occurs in the setting of neurodevelopment (3) . Intrinsic effects of HIV-l on the infant's CNS include microcephaly, diffuse gliosis, and basal ganglia mineralization (3) . In addition, an intrinsic HIV-l-induced damage has been indirectly demonstrated by the successful treatment of various forms of dementia and neurologic symptoms with zidovudine (4) (5) (6) . Moreover, HIV-infected children have altered cortisol secretion, probably associated with specific CNS damage (7) . The pathogenic mechanisms of neurologic dysfunction and detectable. This would exclude the possibility that tat would be transduced by these cells. GI-CA-N stained negative for CD4, although positive for Gal-C, which may explain HIV-1 entry. Results show that immature human neural cells interact with tat protein and/or its basic residue in vitro. A mechanism similar to that herein described would possibly be active in vivo, which may help in clarifying the pathogenic mechanisms of neurologic dysfunction and destruction of the CNS observed in infants infected with HIV-I. destruction-whether a result of direct cellular infection of HIV, secondarily produced and up-regulated cytotoxic cytokines, or co-infection with opportunistic pathogens-remain an area of active research. During early human brain development, HIV-1 may influence the differentiation processes of CD4 -neuroblasts and oligodendrocyte precursors, resulting in dysmyelination and gliosis (1) (2) (3) (4) (5) (6) (7) .
Neural cell adhesion to ECM protein is a crucial step in both neural cell differentiation and function (8) (9) (10) (11) (12) (13) (14) (15) (16) . We recently showed that agents affecting neuroblast differentiation, such as retinoic acid, TNF-a, and y-IFN, modulate NB cell differentiation; this includes integrin receptor expression (17) and induction of HLA class II antigen (18) . Thus, changes in NB cell-adhesion properties are part of the maturational processes induced by the various differentiators (13, 14) . In the nervous system integrins are the major class of adhesion receptors and mediate the differentiating effects of ECM components on neural cells during development (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) .
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The HIV-l trans-activator protein tat has been implicated as a mediator of neuronal dysfunction in several model systems (19) (20) (21) (22) (23) (24) . In a recent report, Kolson et al. (23) showed that tat induced a marked aggregation of neurons and astrocytes in primary rodent brain cell cultures and caused the neuritic processes to coalesce into fascicles, thus affecting neural cell adhesion processes. These effects mapped to a different region from the trans-activation domain of tat, as mutating the RGD sequence within the second exon abrogated aggregation and fascicle formation without affecting trans-activation capacity. PCI2, a rat pheocrornocytorna-derived cell line, would also be affected by tat in their differentiation/proliferation processes (19) .
Proliferation and differentiation of human cells other than neural cells is affected by tat. By studying spindle-shaped cells of vascular origin, that are the probable tumor cells of Kaposi sarcoma, Barillari et al. (24) showed that tat promotes the adhesion of AIDS-Kaposi sarcoma as well as normal vascular cells. Such an adhesion is associated with the amino acid sequence RGD of tat through a specific interaction with the integrin receptors a5f31 and a(v)f33, although it is augmented by the basic region, the 46-60 domain. Moreover, the expression of both integrins is increased by cytokines promoting these cells to acquire spindle morphology and become responsive to the adhesion and growth effects of tat. Barillari's results strongly suggest that RGD-recognizing integrins mediate both adhesion and vascular cell growth-promoting effect of tat.
By studying the modulation of integrin receptors induced by y-IFN in human NB cells, we previously showed a specific modulation of a1f31, a2f31, and a3f31 along with the neural differentiation process (15) . In this report we analyze the adhesion, proliferation, and morphologic changes due to HIV-l tat and discuss the possible implication of neural cell adhesion disturbance by tat in the etiology of CNS damage by HIV-1.
METHODS
Chemicals. Human ECM, including laminin, fibronectin, Coll I, Coll IV, and vitronectin were purchased from Sigma (St Louis, MO). tat-derived peptides were produced by Neosystem (Strasbourg, France); tat 46 -6 0 was synthesized according to the following sequence: S-Y-G-R-K-K-R-R-P-P-Q, whereas the tat 65 -
Poly-o-lysine was purchased from Polyscience Inc. (Warrington PA). FCS, BSA and cell culture media were all from Seromed. VIP and substance P were both from Sigma.
Cell lines. LAN-5 NB cell line was a generous gift of R.
Seeger (UCLA), whereas the GI-CA-N cell line was established in our laboratory as described elsewhere (26) .
Cell adhesion. Cell lines and methods have been previously described in detail (15, 16, (26) (27) (28) (29) . Briefly, GI-CA-N and LAN-5 cells were harvested with PBS, resuspended in RPMI 1640, and seeded on 96-well plates (Costar, Cambridge MA) previously coated with ECM substrates or tat residues (10 f-Lg/ml final concentration on plastic plates preactivated with bis-bromo-sulfosuccynimidyl-suberate, BS3, Pierce). Poly-olysine was used as a control. Coating was performed overnight at 4°C, then the plates were washed twice with PBS and incubated for 1 h at room temperature with 0.1 % BSA in PBS. After two additional washes, cells were plated and incubated for 1 h at 37°C. Unattached cells were washed out with PBS, whereas adherent cells were fixed and stained with cresyl violet in 20% methanol. After solubilization with 0.1 M citric acid in 50% ethanol, A 60 0 was measured by microplate reader Metertech, model 1960. The percentage of cells attached to ECM, poly-p-lysine and tat peptides was calculated as described elsewhere (15) .
To evaluate whether tat fragments were able to compete with ECM proteins, preincubation of both cell lines with tat-derived peptides was performed. Cells were pre incubated for 1 h at 37°C with tat 46 -60 or to tat at the concentration of 100 f-Lg/ml, washed, and tested in the adhesion assay. A preincubation with control peptides, including VIP and substance P, was performed under the same conditions. To test whether Coll I receptor was involved in tat 46 -6 0 recognition, a preincubation with soluble Coll I was performed for 1 h at 37°C. Cells were then washed and tested in the adhesion assay.
Integrin pattern. The expression of integrin receptors was evaluated by means of immunoprecipitation and/or RT-PCR as recently described in detail (15) .
Cell proliferation and morphology. NB cells proliferation was evaluated by eH]TdR incorporation as described before in detail (23) . Morphologic and immunophenotype changes were also evaluated by mean of immunocytochemistry as described elsewhere (15, 16, (26) (27) (28) (29) . Briefly, the percent of positive cells was evaluated by two different researchers, blind to study senses. Data were expressed as the mean ± SD of four different experiments (see Table 2 legend for further details).
Proliferation of NB cells was also tested on 96-well plates precoated with tat residues and control peptides, including substance P and BSA. Cells were seeded on precoated slides, allowed to adhere for 90 min at 37°C, fixed and stained, and evaluated as A 600 by microplate reader as described in Methods. Results are expressed as range obtained in three different experiments performed in duplicate. SO has been omitted being in each case < 10%.
• BSA (blank); ta t 46 -60 and tat 6S-80, synthetic peptides respectively from tat basic residue and RGO-containing motif. 
RESULTS
of HIV-1 p24 antigen in the culture supernatant and by detection of proviral DNA sequences by PCR as follows. peR analysis. HIV-1 proviral DNA was detected according to Schnittman et al. (31) . Briefly, at passages 3, 5, and 7 after infection, GI-CA-N cells were washed and pelleted in PBS, lysed in 0.001% Triton X-100/0.0001% SDS in TDE buffer (10 mM Tris-HCI pH 8.0, 0.5 mM EDTA, pH 8) with 600 J-Lglml proteinase K (Boehringer Manheim, Indianapolis, IN) for 1 h at 56°C, 15 min, at 95°C. The PCR reaction mixture contained 50 J-LI of DNA lysate, 50 pmol of each primer, SK38/SK39 (gag 1551-1578; gag 1638 -1665), 200 J-LM each of four deoxynucleotide triphosphates (Boehringer Manheim), 10 mM Tris-HCI pH 8.3, 2.5 mM MgCl z , 50 mM KCI, 0.2% gelatin, and 2 U of DNA polymerase from Thermus aquaticus (PerkinElmer Corp.)
Ampl ification was carr ied out with a Perkin-Elmer thermocycler 480 (denaturation 94°C, annealing 55°C, extension n oc, 30 cycles). After amplification, 30-pJ aliquots were mixed with 32P-Iabeled SK19 probe, denatured at 94°C, and hybridized at 56°C for 15 min. Autoradiograms of polyacrylamide gels were obtained by exposure to Kodak XAR film at -70°C (see Fig. 3 ).
GI-CA-N cells adhere to all ECM tested, whereas LAN-5 cells attached to Coli I, Coli IV, and laminin but showed very weak adhesion to vitronectin and fibronectin. Both cells were capable of adhering to tat 46 -60 , although not to tat 65 -80 (Fig.  1) . In spite of this both cell lines were able to grow on plastic dishes precoated with either residue (Table 1) .
Results related to competition experiments are reported in Figure 2 , A and B. Inhibition of cell adhesion was evaluated by comparing optical densities. Preincubation of GI-CA-N cells with soluble tat 4 6 - 60 , but not soluble tat 65 -80 , inhibits the attachment of cells to a matrix of CollI ( Fig. 2A) . In the same way, challenging the cells with soluble Coli I inhibits the attachment to a matrix of tat 4 6 -6 0 (Fig. 2B) , thus suggesting the presence of a common ligand for both proteins on the surface of GI-CA-N. (Table 2) . Cell proliferation was not significantly inhibited by culturing LAN5 or GI-CA-N cells on either tat residues (not shown). When cultured on Coli I, both LAN-5 and GI-CA-N cells acquired a neuronal morphology (extension of neuritelike processes and filipodia), whereas cells adhering to tat 46 -6 0 were small, round, and often clustering as pseudo-rosettes. The expression of integrin subunits by both GI-CA-N and LAN-5 cells is summarized in Table 3 . As expected from the adhesion results, the pattern of the two cell lines was different. Both expressed f31 when associated with different a isoforms.
Both GI-CA-N and LAN-5 cells were tested as negative for CD4, confirming previously published results (6) . Figure 3 shows the gradual loss of HIV-l DNA-specific sequence as detected by PCR, in GI-CA-N/B-LCL co-culture. Cells were seaded on precoated slides, allowed to adhere for 90 min at 37°C, fixed, and stained with a standard procedur e, as described . * Gal-C, galactosyl-cerebroside ; HNK-1, human NK-1; GFAP, glyal fibrillar acidic protein; NF, neurofilaments; NGFr , nerve growth factor receptor; N-CAM, neural cell adhesion molecul e; MAG, myelin-associated glycoprotein.
HUMAN NEUROBLASTS ADHERE TO HIV-l tat
t Fluorescence intensity: (neg) negative; (:t ) equivocal; (+) wea kly positive; (+ +) moderately positive; (+ + +) strongly positive . Antibodies used and specific methods have been previou sly specified in detail (8, 16, 17) . 
Ta ble 3. Expression of integrin subunits by GI-CA-N and LAN-5 human neuroblastoma cells

DIS CUSSION
The absence of a4 and a5 subunits in LAN-5 cells explain the weaker adhesion to fibronec tin, compared with GI-CA-N wh ich exp ress these isoforms. Because both cell lines firmly adhere to tat 46 -60 , although not to tat 6 
S -SO
, the integrin receptors invol ved in fibronectin recognition which include a4 and a5 subunits should not be involved. Ad hesion to tat 46 -6 0 is inhibited by preincubating cells with Coll I (Fig . 2) , although not with fibronectin nor with laminin (not shown). In addition, preincubation of cells with tat 46 -6 0 inhibit attachment to the same fragment and to Coll I (Fig. 2) , although not to the other ECM (not shown). Prein cubation with VIP, subs tance P, and tat 6S -SO did not inhibit adhesion to tat 46 -60 nor to Coll I. This is partially in cont rast with Barillari's report (24) . By testing spindle-shaped vascular endothelial cells, these authors demonstrated that the adhesion to HIV-1 tat is associated with the amino acid seq uence RGD through a specific interaction with the integrin receptors a s l3 t and a v l33' although it is augmented by the basic region. In the neural cell model herein descr ibed, the implication of a s and RGD domain cannot be excluded for GI-CA-N, although it is excluded for LAN-5 (Tab le 3; Fig. 1 ). Th us, the role of the basic residue appe ars to be more than just accessory. It is then possible that human neural cells adhere to tat with receptors other than that identified for endothelial cells (24) . By infecting NB cells with HIV-1 we ascertained the lack of permi ssivity of GI-CA -N (CD4 ,-Gal-C +) to the infection. Thus, GI-CA-N cells may possibly allow HIV-1 entry throug h Gal-C, altho ugh not permissive to HIV-1 replication. We do not know yet if infected cells may eventually transduce and secrete tat; experiments to determine this are presently being run in our labor atory . However, it is clear now that neural cells not permissive to HIV-1 infection may adhere to a tat residue which compete with Coli I. The effect of a three-dimensional Coll I preparation on the structural organization of GI-CA-N cells has been recentl y observed in our laboratory (G. Alessandri, unpublished results). In this model, Coli I induces GI-CA-N cell growth arrest and neuronal differentiation. A similar phenomenon has been recentl y observed by BergsteinsDottir et al. (10) in a different neural cell model. Thu s, it is likely that adhesion to tat may perturb the neuronal differentiation processes, including the inhibition of 200 -kD NF expression (Table 2) , by a mech anism prob ably based on Coli I receptor comp etition.
According to Ensoli et at. (33) HIV-1 tat is secre ted by infected cells and possibly degraded by membrane and extracellular proteases to smaller frag ments. By showing here that some of the tat fragments interact with ECM receptors, we confirm that a etiop athogenet ic mechani sm of neur al cell function disrupt ion may be based on such a phenomenon. Result s presented by Cupp et at. (22) would confirm this hypothe sis. These authors demonstrated the ability of the HIV-1 tat protein to increase expression of TGF-{31, a cyto kine with potent immun osuppr essive activity, in human astrocy tic glial cells. Thus, impli cations of the tat-m edi ated induction of TG F-{31 expression and cytokine involvement in the regul ation of immune response and CNS pathol ogy is very likely.
In previous report s we demonstrated that y-IFN and TNF-a , both of wh ich are actively secreted by HIV-1-infected cells, modulat e human neural cell proliferation and differentiation (13, 23, 24) , modifying integrin expression (12) . Thu s, tat, by altering a com plex combination of cytokine regulation and adhesion processes, may affect neuron and accessory cell maturational proces ses. The involvement of tat in altering the expression of cellular regulat ory fac tors, including ECM receptors which, in turn, may mediate the altered physiology of the cells would result in dysmyelinati on and gliosis. Other HIY-1 proteins may also be involved. Recent results in the study in vivo of a mice transgeni c mod el support the evidence that gp120 also play s a key part in Hl V-l-associated nervou s system imp airment (32) . Thus , the interact ion of gp120 and tat in determining the observed neurotoxicity in the deve loping nervous system is very likely.
